| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_13aca21b26cee456a069f562cf3988da
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0ddbeb7a5705bf2f6de81ed96620e637
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_63fbc64389c860aeab1451db13003dc2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5457e146b022e031c6bd6db6e7bbd883
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3e30c86e295f8cdb99bb47176f706dd6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b444c768c304e5a988cb9c33b2a52c13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6184a5846496e3fae4c5ba86cddc4cd5 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-146
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C59-08 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-00 |
| filingDate |
2017-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cf479f34d86cc743ae86a274741276ef
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_78fa15695cdc64281539a9e49261ac5d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_719c157a6807aaccdba36df11890aa5f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_323bf6dffb0f0145ddd4b3da77b863af
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c9656c5e4e647649a4d9ccb59d99a644
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6bafcc28ba7b6e2b464f52f84cf164db |
| publicationDate |
2018-05-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2018092151-A1 |
| titleOfInvention |
Process for the preparation of 2-(e)-n-hydroxy-3-[4-[[[2-(2-methyl-1h-indol-3-yl) ethyl]amino]methyl]phenyl]-2-propenamide 2-hydroxypropanoic acid (1:1) and its polymorphs thereof |
| abstract |
The present invention relates to novel amorphous and crystalline forms of 2-(E)-N-hydroxy-3-[4-[[[2-(2-methyl-1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2-propenamide and its lactate salt and also its process for the preparation thereof. (1a) |
| priorityDate |
2016-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |